P. W. D. du Buf-Vereijken

发表

Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.

J. Wetzels, J. Hofstra, J. Wirtz, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.

J. Wetzels, A. Branten, P. W. D. du Buf-Vereijken, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.

M. Vervloet, J. Wetzels, A. Branten, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil

E. V. van Puijenbroek, P. F. Spooren, J. V. van Doormaal, 1996, Journal of internal medicine.

J. Wetzels, P. W. D. du Buf-Vereijken, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

A. M. Ramos, L. Rimsevicius, D. Abramowicz, 2022, Scientific Reports.

Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months After a Diagnosis of COVID-19

A. M. Ramos, L. Rimsevicius, Dan Constantin Radulescu, 2022, Transplantation.

Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study.

J. Wetzels, F. Bosch, D. Hollander, 2004, Journal of the American Society of Nephrology : JASN.

Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: high renal survival in a large patient cohort.

J. Wetzels, D. Hollander, P. Gerlag, 2004, QJM : monthly journal of the Association of Physicians.

Cinacalcet for secondary hyperparathyroidism: from improved mineral levels to improved mortality?

M. Vervloet, L. Reichert, P. S. Smak Gregoor, 2013, The Netherlands journal of medicine.

Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.

J. Wetzels, A. Branten, P. W. D. du Buf-Vereijken, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Partial renal vein thrombosis in a kidney transplant: management by streptokinase and heparin.

J. Wetzels, L. Hilbrands, P. W. D. du Buf-Vereijken, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.

J. Wetzels, P. W. D. du Buf-Vereijken, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Lyanne M. Kieneker, L. Rimsevicius, U. Maggiore, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Swelling of hand and forearm caused by Mycobacterium bovis.

J. Meis, J. V. D. van der Meer, A. J. van der Ven, 1999, The Netherlands journal of medicine.

U. Maggiore, D. Abramowicz, M. Christiaans, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.